Nvidia (NASDAQ: NVDA) Stock Rating: Stop After Q3 FY1/27 Earnings
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as interim CEO.
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as interim CEO.
@akramsrazor Ultimately, over a 2 to 3 year window, there are: too many GPU/ASIC-TPU suppliers; demand is not sustainable; and there is too much price competition (in the form of loans, gaurantees, and warrants) = thus, they’re all shorts $AMD $AVGO $NVDA
Doesn’t seem like this story is going to die easily. How long until $NVDA’s GC is running the show?
To be honest though, I have successfully short $COST twice in the past, it’s just terribly low beta so even if you time it right it’s a slow trade
CNBC headline: "Nvidia interim CEO Kress talks exclusively to CNBC’s Jim Cramer". Oh no. $NVDA
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
CDW CEO Chris Leahy says AI adoption has reached a make-or-break phase as customers seek trusted guidance amid proliferating IT choices.
Realty Income trades near $58, with 2026 AFFO guidance of $4.45 to $4.46 per share and a 5.5% dividend yield supported by a low-70% payout…
Alphabet’s Google Cloud, Gemini training costs and capex shape the company’s valuation as cloud becomes a larger earnings driver.
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…
Amneal Pharmaceuticals posted its fourth straight earnings beat, with Q3 revenue up 10%, raised FY26 guidance and an expanding biosimilar…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Elanco’s earnings inflection and prospective dividend support targeted low-double-digit EPS growth despite Zoetis discounting.
Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…
Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…
David Orr describes running Militia Capital’s roughly 500-stock long-short portfolio, using expected value, correlation and factor…
Coupang expects Product Commerce margins to return to pre-data incident levels by mid-2027 as customer spending recovers and Taiwan…
Novo Nordisk beat Q3 consensus as Wegovy pill sales reached DKK 5.4bn, raised 2026 guidance again and reported DKK 79.2bn revenue.
Shopify's 3Q 2026 GMV grew 30% FX-neutral, reaching 46% of Amazon retail GMV after merchants captured nearly half of incremental U.S.
AXT reported record Q3 revenue as AI data-center demand for indium phosphide drives supply agreements and capacity expansion.
Tim Isgro discusses reconstructing Li Lu, Eddie Lampert and Mohnish Pabrai investments, AI-assisted research, and Clear Secure, Remitly and…
Eli Lilly uses AI-driven drug discovery and its research scale to accelerate molecule development and broaden its product pipeline.
Gartner’s growth has stalled after federal contract losses and cautious commercial spending, raising questions about its competitive…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.